Hemogenyx Pharmaceuticals Share Discussion Threads

[badger60] 10/1/2023 08:11

Now trading in the 2.20's.......who would have thought?....yesterday it peaked at 2.65p. ....and Muppets like grow on talking 14pps...oh dear!

[badger60] 10/1/2023 08:08

Dear oh dear....the mms putting in very small buy trades at 2.5p while 99% of the volume is being sold in the 2.30's.

[badger60] 09/1/2023 22:53

Closed 35 BP down from the peak at 2.3p. Struggling to maintain the rise. Needs more verbal hype from MadVlad to keep it going or it will fall back towards 2 p. The Muppets will undoubtedly get sucked in before the fundraiser.

[orchestralis] 09/1/2023 18:19

But what is left, will be better quality.

[jotoha2] 09/1/2023 17:40

Solid day and more to come , keep it up Vlad in you and your team we trust.

[david gruen] 09/1/2023 14:45

You won't give them a second thought when this breaks the 14p lid.

[the chairman elect] 09/1/2023 14:30

Only FILTER all the very TROLLS so yes agree doesn't leave that many real posters who aren't out and out c8nts!

[david gruen] 09/1/2023 14:00

David Gruen 9 Jan '23 - 13:42 - 8297 of 8303 (Filtered)

So everyone filters everyone else. Not much of a forum this. It's more an opportunity for self-reflection or prayer.

[the chairman elect] 09/1/2023 13:58

Smithie69 Jan '23 - 13:55 - 8301 of 8302 (Filtered)
Smithie69 Jan '23 - 13:57 - 8302 of 8302 (Filtered)

[smithie6] 09/1/2023 13:57

if filter Chairman & Badger (done)

there are not many posts left !!

[the chairman elect] 09/1/2023 13:46

Any poster that does not allow the use of the c word in relation to culling of vermin TROLLs is automatically filtered!!!!

[david gruen] 09/1/2023 13:44

badger has pushed TCE to use extreme language.

[orchestralis] 09/1/2023 13:43

Anybody who uses the c word gets filtered. It's unnecessary.

[david gruen] 09/1/2023 13:42

I thought (hoped) we'd seen the last of him for good.

[badger60] 09/1/2023 13:02

.....perhaps even lower....

[badger60] 09/1/2023 13:01

Maybe a close at 2.15-2.25 ish....once the mms have rinsed the gullible out of their hard earned..........

[the chairman elect] 09/1/2023 13:00

Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility.

The Company is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as platform technologies that it uses as engines for novel product development.

[badger60] 09/1/2023 12:57

Not easy to pump 900 Mio shares...and keep the share price firm. People will cash in before they get spiked by a new issue....and the share price is getting a tad soggy.

[the chairman elect] 09/1/2023 12:56

Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "We are pleased now to be announcing further exciting developments in our CBR platform. CBR is a ground-breaking new approach to treat existing and emerging viral infections as well as potentially becoming an effective new form of cancer treatment. On the viral front, its potential ability to treat a very wide range of viruses give it the potential to revolutionise the treatment of viral diseases and even to become the means of counteracting biological warfare."

[the chairman elect] 09/1/2023 12:52

Meanwhile, the Company is conducting in vivo tests to demonstrate that CBR could be used against infectious replicating SARS-CoV-2 virus, including its recent dangerous variants.

[the chairman elect] 09/1/2023 12:51

It is important to emphasise that, although our work to date has been focused on certain viruses, in particular SARS-CoV-2, as well as on particular types of cancer, it is in principle applicable to almost any form of virus.

[the chairman elect] 09/1/2023 12:49

It has developed a new proprietary platform technology that is based on harnessing the power of the immune system and has derived potential treatments from it, starting with one that targets SARS-CoV-2, the virus that causes COVID-19